MedTrace Logo

Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

NCT01538017 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-10-04

No results posted yet for this study

Summary

Comparing injectable collagenase and percutaneous needle fasciotomy for Dupuytren's contracture affecting proximal interphalangeal joints. An open label, medico-independent randomized controlled trial.

Conditions

  • Dupuytrens Contracture

Interventions

DRUG

Xiapex

Collagenase Clostridium Histolyticum

PROCEDURE

Percutaneous needle fasciotomy

Percutaneous needle fasciotomy ad modum Lermusiaux and Debeyre

Sponsors & Collaborators

  • Jeppe Lange, MD

    lead OTHER

Principal Investigators

  • Jeppe Lange, M.D. · Regionshospitalet Silkeborg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538017 on ClinicalTrials.gov